Canada
This article was added by the user . TheWorldNews is not responsible for the content of the platform.

New Pfizer-BioNTech Omicron vaccine available in Ontario in weeks: Minister of Health

Author of the article:

The Canadian Press

The Canadian Press

This August 2022 photo provided by Pfizer shows vials of the company's updated COVID-19 vaccine during production in Kalamazoo, Mich. Ontario's health minister says the newly approved Pfizer-BioNTech COVID-19 booster vaccine means youth aged 12 to 17 can get a dose heading into the colder months. THE CANADIAN PRESS/Pfizer via AP
This August 2022 photo provided by Pfizer shows vials of the company's updated COVID-19 vaccine during production in Kalamazoo, Mich. Ontario's health minister says the newly approved Pfizer-BioNTech COVID-19 booster vaccine means youth aged 12 to 17 can get a dose heading into the colder months. THE CANADIAN PRESS/Pfizer via AP THE ASSOCIATED PRESS

TORONTO — Ontario’s health minister says the newly approved Pfizer-BioNTech COVID-19 booster vaccine means youth aged 12 to 17 can get a dose heading into the colder months.

Sylvia Jones says the province is expecting the first shipment of doses of the vaccine that targets the BA.4 and BA.5 strains of the Omicron variant in the coming weeks.

Sign up to receive the daily top stories from the National Post, a division of Postmedia Network Inc.

By clicking on the sign up button you consent to receive the above newsletter from Postmedia Network Inc. You may unsubscribe any time by clicking on the unsubscribe link at the bottom of our emails. Postmedia Network Inc. | 365 Bloor Street East, Toronto, Ontario, M4W 3L4 | 416-383-2300

She says the province is working with public health units to be able to administer those doses as soon as they receive supply from the federal government.

Health Canada approved the new vaccine Friday for people 12 years of age and older.

The vaccine can be given three to six months after a second dose of the primary vaccine or the most recent booster shot.

Health Canada approved a combination shot from Moderna last month that targets the original virus and the Omicron variant, but it was only available for those 18 and older.

This report by The Canadian Press was first published Oct. 7, 2022.